What is a stock summary page? Click here for an overview.
Business Description
Bristol-Myers Squibb Co
NAICS : 325412
SIC : 2834
Description
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.18 | |||||
| Debt-to-Equity | 3.13 | |||||
| Debt-to-EBITDA | 16.16 | |||||
| Interest Coverage | 3.02 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.38 | |||||
| Beneish M-Score | -3.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.9 | |||||
| 3-Year EBITDA Growth Rate | -44.1 | |||||
| 3-Year EPS without NRI Growth Rate | -46.5 | |||||
| 3-Year FCF Growth Rate | 0.4 | |||||
| 3-Year Book Growth Rate | -21.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 62.49 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | -4.36 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.25 | |||||
| Quick Ratio | 1.15 | |||||
| Cash Ratio | 0.46 | |||||
| Days Inventory | 76.37 | |||||
| Days Sales Outstanding | 69.2 | |||||
| Days Payable | 92.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 6.4 | |||||
| 3-Year Average Share Buyback Ratio | 2 | |||||
| Shareholder Yield % | -8.77 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 71.08 | |||||
| Operating Margin % | 12.19 | |||||
| Net Margin % | -18.53 | |||||
| ROE % | -46.41 | |||||
| ROA % | -9.42 | |||||
| ROIC % | 7.58 | |||||
| 3-Year ROIIC % | 8.6 | |||||
| ROC (Joel Greenblatt) % | -78.45 | |||||
| ROCE % | -9 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 75.97 | |||||
| PE Ratio without NRI | 42.71 | |||||
| Shiller PE Ratio | 36.08 | |||||
| PS Ratio | 2.04 | |||||
| PB Ratio | 6.05 | |||||
| Price-to-Free-Cash-Flow | 7.09 | |||||
| Price-to-Operating-Cash-Flow | 6.5 | |||||
| EV-to-EBIT | -21.55 | |||||
| EV-to-EBITDA | 43.74 | |||||
| EV-to-Revenue | 2.87 | |||||
| EV-to-FCF | 9.94 | |||||
| Earnings Yield (Greenblatt) % | -4.64 | |||||
| FCF Yield % | 14.07 | |||||
| Forward Rate of Return (Yacktman) % | 9.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BMY.R
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bristol-Myers Squibb Co Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 4.76 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bristol-Myers Squibb Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bristol-Myers Squibb Co Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bristol-Myers Squibb Co Frequently Asked Questions
What is Bristol-Myers Squibb Co(BMY.R)'s stock price today?
The current price of BMY.R is $0.69. The 52 week high of BMY.R is $4.76 and 52 week low is $0.00.
When is next earnings date of Bristol-Myers Squibb Co(BMY.R)?
The next earnings date of Bristol-Myers Squibb Co(BMY.R) is 2025-07-31.
Does Bristol-Myers Squibb Co(BMY.R) pay dividends? If so, how much?
Bristol-Myers Squibb Co(BMY.R) does not pay dividend.
Guru Commentaries on NYSE:BMY.R
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers